Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

1.470

+0.020 (1.38%)

At close: Mar 3, 2026, 4:00 PM EST

1.360

-0.110 (-7.48%)

Pre-market: Mar 4, 2026, 7:00 AM EST

Aspire Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	1.95	0	-	0.5	-
Cash & Short-Term Investments	1.95	0	-	0.5	-
Inventory	0.04	-	-	-	-
Other Current Assets	0.42	0.14	0.08	0.6	-
Total Current Assets	2.4	0.15	0.08	1.1	-
Long-Term Investments	-	-	19.9	299	-
Other Long-Term Assets	-	-	-	0.08	0.23
Total Assets	2.4	0.15	19.98	300.18	0.23
Accounts Payable	1.06	0.31	0.15	0.18	0
Accrued Expenses	0.27	-	-	-	0.01
Short-Term Debt	7.62	1.27	0.01	-	0.21
Other Current Liabilities	4.91	0.11	0.24	0.12	-
Total Current Liabilities	13.86	1.69	0.4	0.3	0.23
Other Long-Term Liabilities	0.01	0	-	10.81	-
Total Long-Term Liabilities	0.01	-	-	10.81	-
Total Liabilities	13.87	1.69	0.4	11.12	0.23
Common Stock	0	0	0	0	0
Additional Paid-in Capital	11.08	1.23	10.96	-	0.02
Retained Earnings	-22.55	-2.78	-11.29	-9.94	-0.02
Total Common Shareholders' Equity	-11.47	-1.54	-0.32	-9.94	0
Minority Interest	-	-	19.9	299	-
Shareholders' Equity	-11.47	-1.54	19.58	289.07	0
Total Liabilities & Equity	2.4	0.15	19.98	300.18	0.23
Total Debt	7.62	1.27	0.01	0	0.21
Net Cash (Debt)	-5.68	-1.26	-0.01	0.5	-0.21
Net Cash Per Share	-0.01	-0.00	-	12.95	-
Book Value	-11.47	-1.54	-0.32	-9.94	0
Book Value Per Share	-0.02	-0.00	-0.00	-258.89	-
Tangible Book Value	-11.47	-1.54	-0.32	-9.94	0
Tangible Book Value Per Share	-0.02	-0.00	-0.00	-258.89	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q